Navigation Links
Nobles Medical Technologies II's NobleStitch EL Receives Strong Reviews from Physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt

Fountain Valley, California (PRWEB) July 12, 2013

Prof. Dr. Anthony Nobles, CEO of NMT2 also presented the NobleStitch at an all day symposium during the congress. More than 30 cardiologists participated in the all day one on one training sessions. Prof. Dr. Nobles commented, “the response from the cardiology community was overwhelming. The desire to close PFO’s for stroke and migraine was as strong as ever and the physicians unanimously agreed that closing with suture is a significant benefit over the umbrella “device” implant closure”.

Dr. Michael Mullen presented on his experience with the NobleStitch including his recent successful cases performed at the University College Hospital in London. Dr. Mullen commented “the NobleStitch system is potentially the best solution developed to date for PFO closure, this is the only system that can achieve closure without leaving a device behind”.

Ben Brosch, President of Nobles Medical II said, “This is the 4th year of presenting the evolution of the NobleStitch and now that we have entered the market, we are excited for the overwhelming response we received at the CSI”.

About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.

About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open-heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polypropylene suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.

About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum.

Visit Nobles Medical Technologies II

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nobles Medical Technologies II's NobleStitch EL begins Sales in Europe
2. Physician Groups Call for Fewer Medical Tests
3. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
4. CAM therapy combined with conventional medical care may improve treatment of lower back pain
5. Image share project gives patients and physicians anytime, anywhere access to medical images
6. Researchers determine vitamin D blood level for reducing major medical risks in older adults
7. Biomedical researchers receive Hartwell Foundation awards
8. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
9. Fitness in Middle Age Lowers Medical Costs Later: Study
10. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
11. Gene Tests May Not Drive Patients to More Medical Care
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens ... Disorder, Bruxism, and moderate facial wrinkling. While many patients are aware of the benefits ... great success Botox® delivers to those suffering with discomfort, soreness, and pain as a ...
(Date:11/25/2015)... Evanston, IL (PRWEB) , ... November 25, 2015 ... ... homage to six decades of music, friendships, and learning in its 65th Anniversary ... be held Dec. 5-6. , For 65 years, Brillianteen has been ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving (MADD) ... below 10,000 for the first time since 2011. In 2014, there were 9,967 fatalities ... released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were killed in ...
(Date:11/25/2015)... ... November 25, 2015 , ... "When I underwent ... bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. "In order to ... the patent-pending RECOVERY BRA for added comfort and support. The bra is easier ...
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also known ... people who find their cholesterol levels and weight are creeping up are more likely ... don’t have any of the other symptoms. , Thyroid hormone plays a major role ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
(Date:11/25/2015)... , November 25, 2015 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering.  ... the addition of the  "Global Drug ...  report to their offering.  --> ...
Breaking Medicine Technology: